Literature DB >> 11256571

MHC class I molecules, structure and function.

K Natarajan1, H Li, R A Mariuzza, D H Margulies.   

Abstract

MHC class I molecules (MHC-I) are cell surface recognition elements expressed on virtually all somatic cells. These molecules sample peptides generated within the cell and signal the cell's physiological state to effector cells of the immune system, both T lymphocytes and natural killer (NK) cells. In addition, molecules structurally related to MHC-I, collectively known as MHC-Ib, are more specialized and, in some cases, interact with more limited subsets of lymphoid cells. Using the recently determined structure of the classical MHC-I molecule, H-2Dd, as a paradigm for structure and function, we review other MHC-I and MHC-Ib molecules, with an emphasis on how the same basic structural fold is employed by classical MHC-I molecules to bind specific peptides and T cell receptors, and is exploited by the MHC-Ib molecules in more stringent molecular interactions. It is instructive that structurally related molecules have evolved to perform a number of unique and distinct functions in immune and non-immune recognition.

Mesh:

Substances:

Year:  1999        PMID: 11256571

Source DB:  PubMed          Journal:  Rev Immunogenet        ISSN: 1398-1714


  31 in total

Review 1.  Rational design of peptide-based tumor vaccines.

Authors:  Wilson S Meng; Lisa H Butterfield
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

2.  Structural engineering of pMHC reagents for T cell vaccines and diagnostics.

Authors:  Vesselin Mitaksov; Steven M Truscott; Lonnie Lybarger; Janet M Connolly; Ted H Hansen; Daved H Fremont
Journal:  Chem Biol       Date:  2007-08

3.  The crystal structure of avian CD1 reveals a smaller, more primordial antigen-binding pocket compared to mammalian CD1.

Authors:  Dirk M Zajonc; Harald Striegl; Christopher C Dascher; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

4.  The nature of peptides presented by an HLA class I low expression allele.

Authors:  Jan Hinrichs; Daniel Föll; Christina Bade-Döding; Trevor Huyton; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

5.  Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.

Authors:  M Scott Killian; Fernando Teque; Ramu Sudhagoni
Journal:  Immunogenetics       Date:  2017-07-22       Impact factor: 2.846

6.  A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I molecules to the plasma membrane.

Authors:  Steve Caplan; Naava Naslavsky; Lisa M Hartnell; Robert Lodge; Roman S Polishchuk; Julie G Donaldson; Juan S Bonifacino
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

7.  A potential role for shed soluble major histocompatibility class I molecules as modulators of neurite outgrowth.

Authors:  Lorraine R Washburn; Dan Zekzer; Shoshana Eitan; Yuxin Lu; Hoa Dang; Blake Middleton; Christopher J Evans; Jide Tian; Daniel L Kaufman
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

8.  A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands.

Authors:  Christina Bade-Doeding; Holger-Andreas Elsner; Britta Eiz-Vesper; Axel Seltsam; Ute Holtkamp; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2004-04-30       Impact factor: 2.846

9.  Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity.

Authors:  Kerstin Herzer; Christine S Falk; Jens Encke; Sören T Eichhorst; Axel Ulsenheimer; Barbara Seliger; Peter H Krammer
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153.

Authors:  Janet Mans; Kannan Natarajan; Andrea Balbo; Peter Schuck; Daniel Eikel; Sonja Hess; Howard Robinson; Hrvoje Simic; Stipan Jonjic; Caroline T Tiemessen; David H Margulies
Journal:  J Biol Chem       Date:  2007-09-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.